Icatibant, a bradykinin B2 receptor antagonist and C1 esterase inhibitor, commonly used for hereditary angioedema, has shown efficacy in ACE inhibitor-induced cases [8,10]. The gene discussed is BDKRB2; the disease is angioedema.